Stay updated on EPIC-HR: Oral COVID-19 Clinical Trial
Sign up to get notified when there's something new on the EPIC-HR: Oral COVID-19 Clinical Trial page.

Latest updates to the EPIC-HR: Oral COVID-19 Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe two screenshots show the same Study Details page (NCT04960202) with only minor, cosmetic differences in layout or styling; no content, sections, or data were added or removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange Detected- Added a government funding notice and operating status guidance and updated to version v3.2.0. - Removed the prior v3.1.0 revision tag.SummaryDifference1%

- Check41 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.1%

- Check55 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2; removed the Back to Top link.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page has updated the citation for a study on COVID-19 treatment, reflecting a new publication date and version number.SummaryDifference0.2%

- Check69 days agoChange DetectedThe webpage has been updated to include new facility names and locations, as well as additional drug information related to Nirmatrelvir and MedlinePlus topics. Notably, some previously listed locations and drug information for Ritonavir have been removed.SummaryDifference15%

Stay in the know with updates to EPIC-HR: Oral COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPIC-HR: Oral COVID-19 Clinical Trial page.